13F

Stock

Cellectar Biosciences, Inc.

CLRB · held by 20 managers

Reported value

$1.04M

Holders

20

+0 new · −0 exited

Holders’ est. mark

−$1.43K

Price effect on 3 books still in the name

Largest holder

$295K

Bleichroeder LP

Notable conviction

Share of each notable manager’s 13F book.

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
Bleichroeder LP100K$295KHeld
Vanguard89.1K$262.9KHeld
DRW Securities, LLC45.2K$133.3KHeld
GEODE CAPITAL MANAGEMENT, LLC28.6K$84.5KHeld
Sequoia Financial Advisors, LLC25.4K$74.8KHeld
Riverview Capital Advisers, LLC10.4K$50.1KHeld
Warberg Asset Management LLC13.9K$41KHeld
XTX Topco Ltd12.2K$36.1KHeld
SUSQUEHANNA INTERNATIONAL GROUP, LLP12.2K$36KHeld
BlackRock, Inc.4.75K$14KHeld
UBS Group AG2.6K$7.66KHeld
Tower Research Capital LLC (TRC)1.83K$5.41KHeld
MORGAN STANLEY510$1.5K−$1.35KCut−$1.35K
TD Waterhouse Canada Inc.63$181Held
BANK OF AMERICA CORP /DE/36$106−$73Cut−$46
SBI Securities Co., Ltd.11$32Held
OSAIC HOLDINGS, INC.7$19Held
US BANCORP \DE\3$9Held
JONES FINANCIAL COMPANIES LLLP3$9Held
DANSKE BANK A/S2$6−$8Cut−$8

Positions as of Q4 2025. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.